The combination of Type i IFN, TNF-α, and cell surface receptor engagement with dendritic cells enables nk cells to overcome immune evasion by dengue virus

Journal of Immunology

Volumn 193, Issue 10, 2014, Pages 5065-5075

  Lim, Daniel Say Liang ^a   Yawata, Nobuyo ^b,c,d   Selva, Kevin John ^b   Li, Na ^e   Tsai, Chen Yu ^a   Yeong, Lai Han ^a   Liong, Ka Hang ^a   Ooi, Eng Eong ^d   Chong, Mun Keat ^a   Ng, Mah Lee ^a   Leo, Yee Sin ^f   Yawata, Makoto ^a,b,c   Wong, Soon Boon Justin ^a,g,h  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b AGENCY FOR SCIENCE   (Singapore)

^c SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

^e SINGAPORE MIT ALLIANCE FOR RESEARCH AND TECHNOLOGY   (Singapore)

^f TAN TOCK SENG HOSPITAL   (Singapore)

^g NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^h NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CELL SURFACE RECEPTOR; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; GRANZYME; HLA ANTIGEN CLASS 1; INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 27; LIPOPOLYSACCHARIDE; PERFORIN; TUMOR NECROSIS FACTOR ALPHA; FAS PROTEIN, HUMAN;

ANTIVIRAL ACTIVITY; ARTICLE; CELL CONTACT; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DENGUE; DENGUE VIRUS; HUMAN; HUMAN CELL; IMMUNE EVASION; IMMUNOSTIMULATION; INNATE IMMUNITY; INTERFERON PRODUCTION; INTRACELLULAR SIGNALING; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PROTEIN EXPRESSION; CELL COMMUNICATION; COCULTURE; CYTOTOXICITY; DENDRITIC CELL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; SIGNAL TRANSDUCTION; VIROLOGY;

ANTIGENS, CD95; CELL COMMUNICATION; COCULTURE TECHNIQUES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; DENGUE VIRUS; FAS LIGAND PROTEIN; GENE EXPRESSION REGULATION; GRANZYMES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNE EVASION; INTERFERON TYPE I; KILLER CELLS, NATURAL; PERFORIN; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84910112341     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302240     Document Type: Article

References (54)

1. World Health Organization and the Special Programme for Research and Training in Tropical Diseases. 2009. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control, New Edition. K. Ciceri and P. Tissot, eds. WHO Press, Geneva, Switzerland, p 3
2. Guzman, A., and R. E. Istúriz. 2010. Update on the global spread of dengue. Int. J. Antimicrob. Agents 36(Suppl. 1): S40-S42
3. MOH. 2013. Ministry of Health, Singapore, epidemiological week 32. Weekly Infectious Disease Bulletin 10
4. Weiskopf, D., M. A. Angelo, E. L. de Azeredo, J. Sidney, J. A. Greenbaum, A. N. Fernando, A. Broadwater, R. V. Kolla, A. D. De Silva, A. M. de Silva, et al. 2013. Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells. Proc. Natl. Acad. Sci. USA 110: E2046-E2053
5. Halstead, S. B. 1979. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J. Infect. Dis. 140: 527-533
6. Halstead, S. B., S. Rojanasuphot, and N. Sangkawibha. 1983. Original antigenic sin in dengue. Am. J. Trop. Med. Hyg. 32: 154-156
7. Avirutnan, P., N. Punyadee, S. Noisakran, C. Komoltri, S. Thiemmeca, K. Auethavornanan, A. Jairungsri, R. Kanlaya, N. Tangthawornchaikul, C. Puttikhunt, et al. 2006. Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J. Infect. Dis. 193: 1078-1088
8. Navarro-Sánchez, E., P. Desprès, and L. Cedillo-Barrón. 2005. Innate immune responses to dengue virus. Arch. Med. Res. 36: 425-435
9. Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17: 189-220
10. Long, E. O., H. S. Kim, D. Liu, M. E. Peterson, and S. Rajagopalan. 2013. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu. Rev. Immunol. 31: 227-258
11. Ljunggren, H. G., and K. Kärre. 1990. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today 11: 237-244
12. Yawata, M., N. Yawata, M. Draghi, F. Partheniou, A. M. Little, and P. Parham. 2008. MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response. Blood 112: 2369-2380
13. Azeredo, E. L., L. M. De Oliveira-Pinto, S. M. Zagne, D. I. Cerqueira, R. M. Nogueira, and C. F. Kubelka. 2006. NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease. Clin. Exp. Immunol. 143: 345-356
14. Green, S., S. Pichyangkul, D. W. Vaughn, S. Kalayanarooj, S. Nimmannitya, A. Nisalak, I. Kurane, A. L. Rothman, and F. A. Ennis. 1999. Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. J. Infect. Dis. 180: 1429-1435
15. Vilches, C., J. Castaño, N. Gómez-Lozano, and E. Estefanía. 2007. Facilitation of KIR genotyping by a PCR-SSP method that amplifies short DNA fragments. Tissue Antigens 70: 415-422
16. Nagler, A., L. L. Lanier, S. Cwirla, and J. H. Phillips. 1989. Comparative studies of human FcRIII-positive and negative natural killer cells. J. Immunol. 143: 3183-3191
17. Jacobs, R., G. Hintzen, A. Kemper, K. Beul, S. Kempf, G. Behrens, K. W. Sykora, and R. E. Schmidt. 2001. CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells. Eur. J. Immunol. 31: 3121-3127
18. Ho, L. J., J. J. Wang, M. F. Shaio, C. L. Kao, D. M. Chang, S. W. Han, and J. H. Lai. 2001. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J. Immunol. 166: 1499-1506
19. Libraty, D. H., S. Pichyangkul, C. Ajariyakhajorn, T. P. Endy, and F. A. Ennis. 2001. Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J. Virol. 75: 3501-3508
20. Bottino, C., R. Biassoni, R. Millo, L. Moretta, and A. Moretta. 2000. The human natural cytotoxicity receptors (NCR) that induce HLA class I-independent NK cell triggering. Hum. Immunol. 61: 1-6
21. Vitale, M., M. Della Chiesa, S. Carlomagno, D. Pende, M. Aricò , L. Moretta, and A. Moretta. 2005. NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood 106: 566-571
22. Hershkovitz, O., B. Rosental, L. A. Rosenberg, M. E. Navarro-Sanchez, S. Jivov, A. Zilka, O. Gershoni-Yahalom, E. Brient-Litzler, H. Bedouelle, J. W. Ho, et al. 2009. NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells. J. Immunol. 183: 2610-2621
23. Welte, S., S. Kuttruff, I. Waldhauer, and A. Steinle. 2006. Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction. Nat. Immunol. 7: 1334-1342
24. Magri, G., A. Muntasell, N. Romo, A. Sáez-Borderías, D. Pende, D. E. Geraghty, H. Hengel, A. Angulo, A. Moretta, and M. López-Botet. 2011. NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirusinfected myeloid dendritic cells overcoming viral immune evasion strategies. Blood 117: 848-856
25. Jarahian, M., C. Watzl, P. Fournier, A. Arnold, D. Djandji, S. Zahedi, A. Cerwenka, A. Paschen, V. Schirrmacher, and F. Momburg. 2009. Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase. J. Virol. 83: 8108-8121
26. Bryceson, Y. T., M. E. March, H. G. Ljunggren, and E. O. Long. 2006. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107: 159-166
27. Tangye, S. G., H. Cherwinski, L. L. Lanier, and J. H. Phillips. 2000. 2B4-mediated activation of human natural killer cells. Mol. Immunol. 37: 493-501
28. Janssen, O., J. Qian, A. Linkermann, and D. Kabelitz. 2003. CD95 ligand-death factor and costimulatory molecule? Cell Death Differ. 10: 1215-1225
29. Newell, M. K., and J. Desbarats. 1999. Fas ligand: receptor or ligand? Apoptosis 4: 311-315
30. Sun, M., K. T. Ames, I. Suzuki, and P. J. Fink. 2006. The cytoplasmic domain of Fas ligand costimulates TCR signals. J. Immunol. 177: 1481-1491
31. Yu, J., G. Heller, J. Chewning, S. Kim, W. M. Yokoyama, and K. C. Hsu. 2007. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands. J. Immunol. 179: 5977-5989
32. Anfossi, N., P. André, S. Guia, C. S. Falk, S. Roetynck, C. A. Stewart, V. Breso, C. Frassati, D. Reviron, D. Middleton, et al. 2006. Human NK cell education by inhibitory receptors for MHC class I. Immunity 25: 331-342
33. Bossi, G., and G. M. Griffiths. 1999. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat. Med. 5: 90-96
34. Wallin, R. P., V. Screpanti, J. Michaëlsson, A. Grandien, and H. G. Ljunggren. 2003. Regulation of perforin-independent NK cell-mediated cytotoxicity. Eur. J. Immunol. 33: 2727-2735
35. Muñoz-Jordán, J. L. 2010. Subversion of interferon by dengue virus. Curr. Top. Microbiol. Immunol. 338: 35-44
36. Wati, S., P. Li, C. J. Burrell, and J. M. Carr. 2007. Dengue virus (DV) replication in monocyte-derived macrophages is not affected by tumor necrosis factor alpha (TNF-αlpha), and DV infection induces altered responsiveness to TNF-αlpha stimulation. J. Virol. 81: 10161-10171
37. Hunter, C. A., K. E. Gabriel, T. Radzanowski, L. E. Neyer, and J. S. Remington. 1997. Type I interferons enhance production of IFN-gamma by NK cells. Immunol. Lett. 59: 1-5
38. Marshall, J. D., D. S. Heeke, C. Abbate, P. Yee, and G. Van Nest. 2006. Induction of interferon-gamma from natural killer cells by immunostimulatory CpG DNA is mediated through plasmacytoid-dendritic-cell-produced interferon-alpha and tumour necrosis factor-alpha. Immunology 117: 38-46
39. Sun, P., S. Fernandez, M. A. Marovich, D. R. Palmer, C. M. Celluzzi, K. Boonnak, Z. Liang, H. Subramanian, K. R. Porter, W. Sun, and T. H. Burgess. 2009. Functional characterization of ex vivo blood myeloid and plasmacytoid dendritic cells after infection with dengue virus. Virology 383: 207-215
40. Jessie, K., M. Y. Fong, S. Devi, S. K. Lam, and K. T. Wong. 2004. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J. Infect. Dis. 189: 1411-1418
41. Marovich, M., G. Grouard-Vogel, M. Louder, M. Eller, W. Sun, S. J. Wu, R. Putvatana, G. Murphy, B. Tassaneetrithep, T. Burgess, et al. 2001. Human dendritic cells as targets of dengue virus infection. J. Investig. Dermatol. Symp. Proc. 6: 219-224
42. Wu, S. J., G. Grouard-Vogel, W. Sun, J. R. Mascola, E. Brachtel, R. Putvatana, M. K. Louder, L. Filgueira, M. A. Marovich, H. K. Wong, et al. 2000. Human skin Langerhans cells are targets of dengue virus infection. Nat. Med. 6: 816-820
43. Tassaneetrithep, B., T. H. Burgess, A. Granelli-Piperno, C. Trumpfheller, J. Finke, W. Sun, M. A. Eller, K. Pattanapanyasat, S. Sarasombath, D. L. Birx, et al. 2003. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 197: 823-829
44. Walzer, T., M. Dalod, S. H. Robbins, L. Zitvogel, and E. Vivier. 2005. Naturalkiller cells and dendritic cells: "l'union fait la force." Blood 106: 2252-2258
45. Moretta, L., G. Ferlazzo, C. Bottino, M. Vitale, D. Pende, M. C. Mingari, and A. Moretta. 2006. Effector and regulatory events during natural killer-dendritic cell interactions. Immunol. Rev. 214: 219-228
46. Lucas, M., W. Schachterle, K. Oberle, P. Aichele, and A. Diefenbach. 2007. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26: 503-517
47. Beuneu, H., J. Deguine, I. Bouvier, J. P. Di Santo, M. L. Albert, and P. Bousso. 2011. Cutting edge: a dual role for type I IFNs during polyinosinic-polycytidylic acid-induced NK cell activation. J. Immunol. 187: 2084-2088
48. Jinushi, M., T. Takehara, T. Kanto, T. Tatsumi, V. Groh, T. Spies, T. Miyagi, T. Suzuki, Y. Sasaki, and N. Hayashi. 2003. Critical role of MHC class I-related chain A and B expression on IFN-α-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection. J. Immunol. 170: 1249-1256
49. Matikainen, S., A. Paananen, M. Miettinen, M. Kurimoto, T. Timonen, I. Julkunen, and T. Sareneva. 2001. IFN-α and IL-18 synergistically enhance IFN-g production in human NK cells: differential regulation of Stat4 activation and IFN-g gene expression by IFN-α and IL-12. Eur. J. Immunol. 31: 2236-2245
50. Rea, D., F. H. Schagen, R. C. Hoeben, M. Mehtali, M. J. Havenga, R. E. Toes, C. J. Melief, and R. Offringa. 1999. Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset. J. Virol. 73: 10245-10253
51. Fugier-Vivier, I., C. Servet-Delprat, P. Rivailler, M. C. Rissoan, Y. J. Liu, and C. Rabourdin-Combe. 1997. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J. Exp. Med. 186: 813-823
52. Sun, J. C., S. Madera, N. A. Bezman, J. N. Beilke, M. H. Kaplan, and L. L. Lanier. 2012. Proinflammatory cytokine signaling required for the generation of natural killer cell memory. J. Exp. Med. 209: 947-954
53. Sun, P., C. M. Celluzzi, M. Marovich, H. Subramanian, M. Eller, S. Widjaja, D. Palmer, K. Porter, W. Sun, and T. Burgess. 2006. CD40 ligand enhances dengue viral infection of dendritic cells: a possible mechanism for T cellmediated immunopathology. J. Immunol. 177: 6497-6503
54. Thananchai, H., G. Gillespie, M. P. Martin, A. Bashirova, N. Yawata, M. Yawata, P. Easterbrook, D. W. McVicar, K. Maenaka, P. Parham, et al. 2007. Cutting edge: allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J. Immunol. 178: 33-37.